Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

By C. Roxburgh, D. McMillan. Future Oncology, 2010

1,006 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. (2014, background): “7) (68–70,92,131,132,134) Pancreatic cancer 4 (4) 466 (1.”
Inflammaging and 'Garb-aging'. (2017, background): “Many epidemiological and biodemographic studies show that biomarkers of inflammation are robust predictors of morbidity (chronic diseases) and mortality in the elderly [1,2].”
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. (2013, background): “For example, there is good evidence that markers of the cute phase response, particularly C-reactive protein and lbumin, are both sensitive and reliable markers of systemic nflammation in cancer patients [4].”
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis (2014, background): “On the basis of these findings, a variety of markers of inflammation have been investigated for association with cancer progression and prognosis (4).”
Cancer cachexia: understanding the molecular basis (2014, unknown): “(AgRP(83-132)) prevents cachexia-related symptoms”